nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Microtubule Inhibition—Paclitaxel—ovarian cancer	0.211	0.58	CiPCiCtD
Ixabepilone—breast cancer—ovarian cancer	0.201	1	CtDrD
Ixabepilone—Microtubule Inhibition—Docetaxel—ovarian cancer	0.153	0.42	CiPCiCtD
Ixabepilone—TUBB3—ovarian cancer	0.134	1	CbGaD
Ixabepilone—TUBB2B—Vinorelbine—ovarian cancer	0.0122	0.0528	CbGbCtD
Ixabepilone—TUBB8—Vinorelbine—ovarian cancer	0.0122	0.0528	CbGbCtD
Ixabepilone—TUBB6—Vinorelbine—ovarian cancer	0.0122	0.0528	CbGbCtD
Ixabepilone—TUBB2A—Vinorelbine—ovarian cancer	0.0122	0.0528	CbGbCtD
Ixabepilone—TUBB3—Vinorelbine—ovarian cancer	0.0122	0.0528	CbGbCtD
Ixabepilone—TUBB4A—Vinorelbine—ovarian cancer	0.0122	0.0528	CbGbCtD
Ixabepilone—TUBB1—Vinorelbine—ovarian cancer	0.0102	0.0441	CbGbCtD
Ixabepilone—TUBB4B—Vinorelbine—ovarian cancer	0.0102	0.0441	CbGbCtD
Ixabepilone—TUBB—Vinorelbine—ovarian cancer	0.0102	0.0441	CbGbCtD
Ixabepilone—TUBB3—Paclitaxel—ovarian cancer	0.00856	0.0371	CbGbCtD
Ixabepilone—TUBB8—Paclitaxel—ovarian cancer	0.00856	0.0371	CbGbCtD
Ixabepilone—TUBB4A—Paclitaxel—ovarian cancer	0.00856	0.0371	CbGbCtD
Ixabepilone—TUBB2B—Paclitaxel—ovarian cancer	0.00856	0.0371	CbGbCtD
Ixabepilone—TUBB2A—Paclitaxel—ovarian cancer	0.00856	0.0371	CbGbCtD
Ixabepilone—TUBB6—Paclitaxel—ovarian cancer	0.00856	0.0371	CbGbCtD
Ixabepilone—TUBB—Paclitaxel—ovarian cancer	0.00716	0.031	CbGbCtD
Ixabepilone—TUBB1—Paclitaxel—ovarian cancer	0.00716	0.031	CbGbCtD
Ixabepilone—TUBB4B—Paclitaxel—ovarian cancer	0.00716	0.031	CbGbCtD
Ixabepilone—TUBB6—Docetaxel—ovarian cancer	0.00619	0.0268	CbGbCtD
Ixabepilone—TUBB4A—Docetaxel—ovarian cancer	0.00619	0.0268	CbGbCtD
Ixabepilone—TUBB2A—Docetaxel—ovarian cancer	0.00619	0.0268	CbGbCtD
Ixabepilone—TUBB2B—Docetaxel—ovarian cancer	0.00619	0.0268	CbGbCtD
Ixabepilone—TUBB8—Docetaxel—ovarian cancer	0.00619	0.0268	CbGbCtD
Ixabepilone—TUBB3—Docetaxel—ovarian cancer	0.00619	0.0268	CbGbCtD
Ixabepilone—TUBB1—Docetaxel—ovarian cancer	0.00517	0.0224	CbGbCtD
Ixabepilone—TUBB—Docetaxel—ovarian cancer	0.00517	0.0224	CbGbCtD
Ixabepilone—TUBB4B—Docetaxel—ovarian cancer	0.00517	0.0224	CbGbCtD
Ixabepilone—TUBB4B—oviduct—ovarian cancer	0.000812	0.0556	CbGeAlD
Ixabepilone—CYP3A4—Topotecan—ovarian cancer	0.000617	0.00267	CbGbCtD
Ixabepilone—CYP3A4—Vinorelbine—ovarian cancer	0.000434	0.00188	CbGbCtD
Ixabepilone—TUBB1—decidua—ovarian cancer	0.000397	0.0272	CbGeAlD
Ixabepilone—TUBB8—testis—ovarian cancer	0.000377	0.0259	CbGeAlD
Ixabepilone—TUBB2B—myometrium—ovarian cancer	0.000322	0.0221	CbGeAlD
Ixabepilone—TUBB4A—embryo—ovarian cancer	0.00032	0.0219	CbGeAlD
Ixabepilone—CYP3A4—Paclitaxel—ovarian cancer	0.000305	0.00132	CbGbCtD
Ixabepilone—TUBB—myometrium—ovarian cancer	0.000305	0.0209	CbGeAlD
Ixabepilone—TUBB2A—myometrium—ovarian cancer	0.000303	0.0208	CbGeAlD
Ixabepilone—TUBB6—myometrium—ovarian cancer	0.000299	0.0205	CbGeAlD
Ixabepilone—TUBB1—bone marrow—ovarian cancer	0.000294	0.0202	CbGeAlD
Ixabepilone—TUBB4B—myometrium—ovarian cancer	0.00026	0.0178	CbGeAlD
Ixabepilone—TUBB4A—uterine cervix—ovarian cancer	0.000259	0.0178	CbGeAlD
Ixabepilone—TUBB3—testis—ovarian cancer	0.000257	0.0176	CbGeAlD
Ixabepilone—TUBB1—testis—ovarian cancer	0.000252	0.0173	CbGeAlD
Ixabepilone—TUBB2B—uterine cervix—ovarian cancer	0.00025	0.0172	CbGeAlD
Ixabepilone—TUBB4B—embryo—ovarian cancer	0.00025	0.0171	CbGeAlD
Ixabepilone—TUBB—uterine cervix—ovarian cancer	0.000237	0.0162	CbGeAlD
Ixabepilone—TUBB2A—uterine cervix—ovarian cancer	0.000236	0.0162	CbGeAlD
Ixabepilone—TUBB6—epithelium—ovarian cancer	0.000234	0.0161	CbGeAlD
Ixabepilone—TUBB6—uterine cervix—ovarian cancer	0.000232	0.0159	CbGeAlD
Ixabepilone—TUBB2B—endometrium—ovarian cancer	0.000226	0.0155	CbGeAlD
Ixabepilone—TUBB—decidua—ovarian cancer	0.000226	0.0155	CbGeAlD
Ixabepilone—TUBB2A—decidua—ovarian cancer	0.000225	0.0154	CbGeAlD
Ixabepilone—TUBB6—decidua—ovarian cancer	0.000221	0.0152	CbGeAlD
Ixabepilone—CYP3A4—Docetaxel—ovarian cancer	0.000221	0.000956	CbGbCtD
Ixabepilone—TUBB4A—gonad—ovarian cancer	0.000217	0.0149	CbGeAlD
Ixabepilone—TUBB4A—uterus—ovarian cancer	0.000216	0.0148	CbGeAlD
Ixabepilone—TUBB—endometrium—ovarian cancer	0.000214	0.0147	CbGeAlD
Ixabepilone—TUBB2A—endometrium—ovarian cancer	0.000213	0.0146	CbGeAlD
Ixabepilone—TUBB6—endometrium—ovarian cancer	0.00021	0.0144	CbGeAlD
Ixabepilone—TUBB2B—gonad—ovarian cancer	0.00021	0.0144	CbGeAlD
Ixabepilone—TUBB4B—uterine cervix—ovarian cancer	0.000202	0.0139	CbGeAlD
Ixabepilone—TUBB—uterus—ovarian cancer	0.000197	0.0135	CbGeAlD
Ixabepilone—TUBB2A—uterus—ovarian cancer	0.000196	0.0135	CbGeAlD
Ixabepilone—TUBB6—gonad—ovarian cancer	0.000195	0.0134	CbGeAlD
Ixabepilone—TUBB4A—female reproductive system—ovarian cancer	0.000194	0.0133	CbGeAlD
Ixabepilone—TUBB6—uterus—ovarian cancer	0.000194	0.0133	CbGeAlD
Ixabepilone—TUBB4B—decidua—ovarian cancer	0.000193	0.0132	CbGeAlD
Ixabepilone—TUBB2B—female reproductive system—ovarian cancer	0.000188	0.0129	CbGeAlD
Ixabepilone—TUBB4B—endometrium—ovarian cancer	0.000183	0.0125	CbGeAlD
Ixabepilone—TUBB4A—female gonad—ovarian cancer	0.000177	0.0121	CbGeAlD
Ixabepilone—TUBB2A—female reproductive system—ovarian cancer	0.000177	0.0121	CbGeAlD
Ixabepilone—TUBB6—female reproductive system—ovarian cancer	0.000174	0.0119	CbGeAlD
Ixabepilone—TUBB2B—female gonad—ovarian cancer	0.000171	0.0117	CbGeAlD
Ixabepilone—TUBB2B—vagina—ovarian cancer	0.00017	0.0116	CbGeAlD
Ixabepilone—TUBB4B—gonad—ovarian cancer	0.00017	0.0116	CbGeAlD
Ixabepilone—TUBB4B—uterus—ovarian cancer	0.000168	0.0115	CbGeAlD
Ixabepilone—TUBB—bone marrow—ovarian cancer	0.000168	0.0115	CbGeAlD
Ixabepilone—TUBB2A—bone marrow—ovarian cancer	0.000167	0.0114	CbGeAlD
Ixabepilone—CYP3A4—Doxorubicin—ovarian cancer	0.000164	0.000713	CbGbCtD
Ixabepilone—TUBB6—bone marrow—ovarian cancer	0.000164	0.0113	CbGeAlD
Ixabepilone—TUBB—female gonad—ovarian cancer	0.000162	0.0111	CbGeAlD
Ixabepilone—TUBB2A—female gonad—ovarian cancer	0.000161	0.011	CbGeAlD
Ixabepilone—TUBB—vagina—ovarian cancer	0.000161	0.011	CbGeAlD
Ixabepilone—TUBB2A—vagina—ovarian cancer	0.00016	0.0109	CbGeAlD
Ixabepilone—TUBB6—female gonad—ovarian cancer	0.000158	0.0109	CbGeAlD
Ixabepilone—TUBB6—vagina—ovarian cancer	0.000158	0.0108	CbGeAlD
Ixabepilone—TUBB4A—testis—ovarian cancer	0.000157	0.0107	CbGeAlD
Ixabepilone—TUBB2B—testis—ovarian cancer	0.000151	0.0104	CbGeAlD
Ixabepilone—TUBB4B—female reproductive system—ovarian cancer	0.000151	0.0104	CbGeAlD
Ixabepilone—TUBB—testis—ovarian cancer	0.000143	0.00982	CbGeAlD
Ixabepilone—TUBB4B—bone marrow—ovarian cancer	0.000143	0.0098	CbGeAlD
Ixabepilone—TUBB2A—testis—ovarian cancer	0.000143	0.00977	CbGeAlD
Ixabepilone—TUBB6—testis—ovarian cancer	0.000141	0.00964	CbGeAlD
Ixabepilone—TUBB4B—female gonad—ovarian cancer	0.000138	0.00944	CbGeAlD
Ixabepilone—TUBB4B—vagina—ovarian cancer	0.000137	0.00939	CbGeAlD
Ixabepilone—TUBB4B—testis—ovarian cancer	0.000122	0.00838	CbGeAlD
Ixabepilone—TUBB4A—lymph node—ovarian cancer	0.000114	0.00778	CbGeAlD
Ixabepilone—TUBB2B—lymph node—ovarian cancer	0.00011	0.00752	CbGeAlD
Ixabepilone—TUBB—lymph node—ovarian cancer	0.000104	0.00712	CbGeAlD
Ixabepilone—TUBB2A—lymph node—ovarian cancer	0.000103	0.00708	CbGeAlD
Ixabepilone—TUBB6—lymph node—ovarian cancer	0.000102	0.00698	CbGeAlD
Ixabepilone—TUBB4B—lymph node—ovarian cancer	8.86e-05	0.00607	CbGeAlD
Ixabepilone—CYP3A4—female reproductive system—ovarian cancer	6.22e-05	0.00426	CbGeAlD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	5.31e-05	0.00277	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	5.31e-05	0.00277	CbGpPWpGaD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—PPP2R1A—ovarian cancer	5.3e-05	0.00277	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—PPP2R1A—ovarian cancer	5.28e-05	0.00276	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	5.26e-05	0.00275	CbGpPWpGaD
Ixabepilone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	5.26e-05	0.00275	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—TLR4—ovarian cancer	5.14e-05	0.00268	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	5.13e-05	0.00268	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RSF1—ovarian cancer	5.1e-05	0.00266	CbGpPWpGaD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	4.97e-05	0.00259	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—ovarian cancer	4.96e-05	0.00259	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	4.86e-05	0.00253	CbGpPWpGaD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—PPP2R1A—ovarian cancer	4.85e-05	0.00253	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—PPP2R1A—ovarian cancer	4.8e-05	0.00251	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—PPP2R1A—ovarian cancer	4.73e-05	0.00247	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ovarian cancer	4.7e-05	0.00246	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MUC16—ovarian cancer	4.62e-05	0.00241	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MUC16—ovarian cancer	4.62e-05	0.00241	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MUC16—ovarian cancer	4.46e-05	0.00233	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	4.36e-05	0.00228	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—MUC16—ovarian cancer	4.32e-05	0.00225	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—MUC16—ovarian cancer	4.22e-05	0.0022	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CDH1—ovarian cancer	3.99e-05	0.00208	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—PPP2R1A—ovarian cancer	3.98e-05	0.00208	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—PPP2R1A—ovarian cancer	3.92e-05	0.00205	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	3.92e-05	0.00205	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	3.92e-05	0.00205	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	3.88e-05	0.00203	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MUC16—ovarian cancer	3.79e-05	0.00198	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	3.78e-05	0.00198	CbGpPWpGaD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	3.67e-05	0.00191	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—PPP2R1A—ovarian cancer	3.64e-05	0.0019	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—PPP2R1A—ovarian cancer	3.59e-05	0.00187	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	3.58e-05	0.00187	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—RAD51C—ovarian cancer	3.54e-05	0.00185	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MUC16—ovarian cancer	3.47e-05	0.00181	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	3.46e-05	0.00181	CbGpPWpGaD
Ixabepilone—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	3.34e-05	0.00174	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	3.22e-05	0.00168	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—TP53—ovarian cancer	3.21e-05	0.00168	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RBL2—ovarian cancer	3.18e-05	0.00166	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—PPP1CC—ovarian cancer	3.09e-05	0.00161	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—AQP3—ovarian cancer	3.04e-05	0.00159	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—AQP3—ovarian cancer	3.04e-05	0.00159	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—INHA—ovarian cancer	2.98e-05	0.00155	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—INHA—ovarian cancer	2.98e-05	0.00155	CbGpPWpGaD
Ixabepilone—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	2.95e-05	0.00154	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—ovarian cancer	2.94e-05	0.00154	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.94e-05	0.00153	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—RAD51C—ovarian cancer	2.93e-05	0.00153	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.92e-05	0.00152	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.92e-05	0.00152	CbGpPWpGaD
Ixabepilone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	2.88e-05	0.0015	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—INHA—ovarian cancer	2.87e-05	0.0015	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	2.87e-05	0.0015	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.85e-05	0.00149	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—RBL2—ovarian cancer	2.84e-05	0.00148	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.82e-05	0.00147	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.78e-05	0.00145	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—INHA—ovarian cancer	2.78e-05	0.00145	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.73e-05	0.00143	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—INHA—ovarian cancer	2.72e-05	0.00142	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RAD51C—ovarian cancer	2.68e-05	0.0014	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.67e-05	0.00139	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RBL2—ovarian cancer	2.63e-05	0.00137	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	2.62e-05	0.00137	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PPP1CC—ovarian cancer	2.56e-05	0.00134	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.5e-05	0.00131	CbGpPWpGaD
Ixabepilone—Headache—Topotecan—ovarian cancer	2.47e-05	0.000672	CcSEcCtD
Ixabepilone—Angiopathy—Docetaxel—ovarian cancer	2.46e-05	0.000668	CcSEcCtD
Ixabepilone—Vomiting—Melphalan—ovarian cancer	2.46e-05	0.000668	CcSEcCtD
Ixabepilone—Dehydration—Epirubicin—ovarian cancer	2.46e-05	0.000668	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—ovarian cancer	2.45e-05	0.000667	CcSEcCtD
Ixabepilone—Immune system disorder—Docetaxel—ovarian cancer	2.45e-05	0.000666	CcSEcCtD
Ixabepilone—Loss of consciousness—Paclitaxel—ovarian cancer	2.45e-05	0.000665	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	2.44e-05	0.000665	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—INHA—ovarian cancer	2.44e-05	0.00128	CbGpPWpGaD
Ixabepilone—Mediastinal disorder—Docetaxel—ovarian cancer	2.44e-05	0.000664	CcSEcCtD
Ixabepilone—Rash—Melphalan—ovarian cancer	2.44e-05	0.000663	CcSEcCtD
Ixabepilone—Dermatitis—Melphalan—ovarian cancer	2.43e-05	0.000662	CcSEcCtD
Ixabepilone—Chills—Docetaxel—ovarian cancer	2.43e-05	0.000661	CcSEcCtD
Ixabepilone—Cough—Paclitaxel—ovarian cancer	2.43e-05	0.00066	CcSEcCtD
Ixabepilone—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	2.42e-05	0.00127	CbGpPWpGaD
Ixabepilone—Asthenia—Vinorelbine—ovarian cancer	2.42e-05	0.000659	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RBL2—ovarian cancer	2.41e-05	0.00126	CbGpPWpGaD
Ixabepilone—Hypokalaemia—Epirubicin—ovarian cancer	2.4e-05	0.000654	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.4e-05	0.00125	CbGpPWpGaD
Ixabepilone—Alopecia—Docetaxel—ovarian cancer	2.39e-05	0.000651	CcSEcCtD
Ixabepilone—Pruritus—Vinorelbine—ovarian cancer	2.39e-05	0.00065	CcSEcCtD
Ixabepilone—Mental disorder—Docetaxel—ovarian cancer	2.37e-05	0.000646	CcSEcCtD
Ixabepilone—Myalgia—Paclitaxel—ovarian cancer	2.37e-05	0.000644	CcSEcCtD
Ixabepilone—Chest pain—Paclitaxel—ovarian cancer	2.37e-05	0.000644	CcSEcCtD
Ixabepilone—Arthralgia—Paclitaxel—ovarian cancer	2.37e-05	0.000644	CcSEcCtD
Ixabepilone—Malnutrition—Docetaxel—ovarian cancer	2.36e-05	0.000641	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	2.35e-05	0.00064	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—RBL2—ovarian cancer	2.35e-05	0.00123	CbGpPWpGaD
Ixabepilone—Nausea—Topotecan—ovarian cancer	2.34e-05	0.000638	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—PPP1CC—ovarian cancer	2.34e-05	0.00122	CbGpPWpGaD
Ixabepilone—Gastritis—Epirubicin—ovarian cancer	2.34e-05	0.000636	CcSEcCtD
Ixabepilone—Muscular weakness—Epirubicin—ovarian cancer	2.33e-05	0.000634	CcSEcCtD
Ixabepilone—Diarrhoea—Vinorelbine—ovarian cancer	2.31e-05	0.000628	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.31e-05	0.0012	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.31e-05	0.0012	CbGpPWpGaD
Ixabepilone—Nausea—Melphalan—ovarian cancer	2.3e-05	0.000624	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.29e-05	0.00119	CbGpPWpGaD
Ixabepilone—Dysphagia—Epirubicin—ovarian cancer	2.28e-05	0.000621	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—ovarian cancer	2.27e-05	0.000618	CcSEcCtD
Ixabepilone—Oedema—Paclitaxel—ovarian cancer	2.27e-05	0.000618	CcSEcCtD
Ixabepilone—Muscle spasms—Docetaxel—ovarian cancer	2.27e-05	0.000617	CcSEcCtD
Ixabepilone—Infection—Paclitaxel—ovarian cancer	2.26e-05	0.000614	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—INHA—ovarian cancer	2.23e-05	0.00117	CbGpPWpGaD
Ixabepilone—Shock—Paclitaxel—ovarian cancer	2.23e-05	0.000608	CcSEcCtD
Ixabepilone—Dizziness—Vinorelbine—ovarian cancer	2.23e-05	0.000607	CcSEcCtD
Ixabepilone—Nervous system disorder—Paclitaxel—ovarian cancer	2.23e-05	0.000606	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—ovarian cancer	2.22e-05	0.000605	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—ovarian cancer	2.22e-05	0.000605	CcSEcCtD
Ixabepilone—Thrombocytopenia—Paclitaxel—ovarian cancer	2.22e-05	0.000605	CcSEcCtD
Ixabepilone—Skin disorder—Paclitaxel—ovarian cancer	2.21e-05	0.0006	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.19e-05	0.00114	CbGpPWpGaD
Ixabepilone—Anaemia—Docetaxel—ovarian cancer	2.18e-05	0.000593	CcSEcCtD
Ixabepilone—Pancytopenia—Epirubicin—ovarian cancer	2.17e-05	0.00059	CcSEcCtD
Ixabepilone—Anorexia—Paclitaxel—ovarian cancer	2.16e-05	0.000589	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—ovarian cancer	2.16e-05	0.000588	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.16e-05	0.00113	CbGpPWpGaD
Ixabepilone—Muscular weakness—Doxorubicin—ovarian cancer	2.16e-05	0.000586	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—RBL2—ovarian cancer	2.15e-05	0.00112	CbGpPWpGaD
Ixabepilone—Vomiting—Vinorelbine—ovarian cancer	2.15e-05	0.000584	CcSEcCtD
Ixabepilone—Neutropenia—Epirubicin—ovarian cancer	2.14e-05	0.000581	CcSEcCtD
Ixabepilone—Rash—Vinorelbine—ovarian cancer	2.13e-05	0.000579	CcSEcCtD
Ixabepilone—Dermatitis—Vinorelbine—ovarian cancer	2.13e-05	0.000578	CcSEcCtD
Ixabepilone—Hypotension—Paclitaxel—ovarian cancer	2.12e-05	0.000577	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Epirubicin—ovarian cancer	2.12e-05	0.000577	CcSEcCtD
Ixabepilone—Headache—Vinorelbine—ovarian cancer	2.12e-05	0.000575	CcSEcCtD
Ixabepilone—Syncope—Docetaxel—ovarian cancer	2.12e-05	0.000575	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—ovarian cancer	2.11e-05	0.000574	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—SKP2—ovarian cancer	2.11e-05	0.0011	CbGpPWpGaD
Ixabepilone—Leukopenia—Docetaxel—ovarian cancer	2.11e-05	0.000574	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.11e-05	0.0011	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—TUBB3—ovarian cancer	2.1e-05	0.00109	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—TUBB3—ovarian cancer	2.1e-05	0.00109	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Docetaxel—ovarian cancer	2.07e-05	0.000564	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	2.07e-05	0.000563	CcSEcCtD
Ixabepilone—Weight decreased—Epirubicin—ovarian cancer	2.07e-05	0.000562	CcSEcCtD
Ixabepilone—Cough—Docetaxel—ovarian cancer	2.06e-05	0.00056	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—ovarian cancer	2.06e-05	0.00056	CcSEcCtD
Ixabepilone—Insomnia—Paclitaxel—ovarian cancer	2.05e-05	0.000559	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—ovarian cancer	2.05e-05	0.000557	CcSEcCtD
Ixabepilone—Paraesthesia—Paclitaxel—ovarian cancer	2.04e-05	0.000555	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—ovarian cancer	2.04e-05	0.000554	CcSEcCtD
Ixabepilone—Infestation NOS—Epirubicin—ovarian cancer	2.04e-05	0.000554	CcSEcCtD
Ixabepilone—Dyspnoea—Paclitaxel—ovarian cancer	2.02e-05	0.000551	CcSEcCtD
Ixabepilone—Myalgia—Docetaxel—ovarian cancer	2.01e-05	0.000546	CcSEcCtD
Ixabepilone—Arthralgia—Docetaxel—ovarian cancer	2.01e-05	0.000546	CcSEcCtD
Ixabepilone—Chest pain—Docetaxel—ovarian cancer	2.01e-05	0.000546	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—ovarian cancer	2.01e-05	0.000546	CcSEcCtD
Ixabepilone—Nausea—Vinorelbine—ovarian cancer	2.01e-05	0.000545	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—ovarian cancer	2e-05	0.000544	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—ovarian cancer	2e-05	0.000543	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	1.99e-05	0.000542	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—ovarian cancer	1.98e-05	0.00054	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—ovarian cancer	1.98e-05	0.00054	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—ovarian cancer	1.98e-05	0.000538	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—ovarian cancer	1.98e-05	0.000537	CcSEcCtD
Ixabepilone—Decreased appetite—Paclitaxel—ovarian cancer	1.97e-05	0.000537	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	1.96e-05	0.000534	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—TUBB3—ovarian cancer	1.96e-05	0.00102	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	1.96e-05	0.000533	CcSEcCtD
Ixabepilone—Fatigue—Paclitaxel—ovarian cancer	1.96e-05	0.000532	CcSEcCtD
Ixabepilone—Pain—Paclitaxel—ovarian cancer	1.94e-05	0.000528	CcSEcCtD
Ixabepilone—Constipation—Paclitaxel—ovarian cancer	1.94e-05	0.000528	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Epirubicin—ovarian cancer	1.93e-05	0.000524	CcSEcCtD
Ixabepilone—Oedema—Docetaxel—ovarian cancer	1.93e-05	0.000523	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—TUBB3—ovarian cancer	1.92e-05	0.001	CbGpPWpGaD
Ixabepilone—Infection—Docetaxel—ovarian cancer	1.91e-05	0.00052	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—ovarian cancer	1.91e-05	0.00052	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—MLH1—ovarian cancer	1.91e-05	0.000997	CbGpPWpGaD
Ixabepilone—Pneumonia—Doxorubicin—ovarian cancer	1.89e-05	0.000515	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.89e-05	0.000989	CbGpPWpGaD
Ixabepilone—Shock—Docetaxel—ovarian cancer	1.89e-05	0.000515	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—SKP2—ovarian cancer	1.89e-05	0.000986	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Docetaxel—ovarian cancer	1.89e-05	0.000513	CcSEcCtD
Ixabepilone—Thrombocytopenia—Docetaxel—ovarian cancer	1.88e-05	0.000513	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—ovarian cancer	1.88e-05	0.000512	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—ovarian cancer	1.88e-05	0.000512	CcSEcCtD
Ixabepilone—Skin disorder—Docetaxel—ovarian cancer	1.87e-05	0.000508	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Paclitaxel—ovarian cancer	1.86e-05	0.000505	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—ovarian cancer	1.85e-05	0.000504	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—ovarian cancer	1.85e-05	0.000502	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—ovarian cancer	1.84e-05	0.000499	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—ovarian cancer	1.84e-05	0.000499	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—ovarian cancer	1.84e-05	0.000499	CcSEcCtD
Ixabepilone—Anorexia—Docetaxel—ovarian cancer	1.83e-05	0.000499	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—ovarian cancer	1.83e-05	0.000498	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—ovarian cancer	1.83e-05	0.000497	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—ovarian cancer	1.82e-05	0.000494	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—ovarian cancer	1.8e-05	0.000491	CcSEcCtD
Ixabepilone—Hypotension—Docetaxel—ovarian cancer	1.8e-05	0.000489	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—ovarian cancer	1.8e-05	0.000488	CcSEcCtD
Ixabepilone—Abdominal pain—Paclitaxel—ovarian cancer	1.8e-05	0.000488	CcSEcCtD
Ixabepilone—Body temperature increased—Paclitaxel—ovarian cancer	1.8e-05	0.000488	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—ovarian cancer	1.79e-05	0.000487	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—ovarian cancer	1.78e-05	0.000484	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—ATF3—ovarian cancer	1.77e-05	0.000924	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—ATF3—ovarian cancer	1.77e-05	0.000924	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	1.75e-05	0.000477	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—SKP2—ovarian cancer	1.75e-05	0.000914	CbGpPWpGaD
Ixabepilone—Insomnia—Docetaxel—ovarian cancer	1.74e-05	0.000473	CcSEcCtD
Ixabepilone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	1.74e-05	0.000906	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.73e-05	0.000905	CbGpPWpGaD
Ixabepilone—Paraesthesia—Docetaxel—ovarian cancer	1.73e-05	0.00047	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—ovarian cancer	1.73e-05	0.00047	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—TUBB3—ovarian cancer	1.72e-05	0.000899	CbGpPWpGaD
Ixabepilone—Dyspnoea—Docetaxel—ovarian cancer	1.72e-05	0.000467	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—ATF3—ovarian cancer	1.71e-05	0.000892	CbGpPWpGaD
Ixabepilone—Eye disorder—Epirubicin—ovarian cancer	1.71e-05	0.000464	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—ovarian cancer	1.7e-05	0.000462	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—ovarian cancer	1.7e-05	0.000461	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—ovarian cancer	1.69e-05	0.00046	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—ovarian cancer	1.68e-05	0.000458	CcSEcCtD
Ixabepilone—Decreased appetite—Docetaxel—ovarian cancer	1.67e-05	0.000455	CcSEcCtD
Ixabepilone—Hypersensitivity—Paclitaxel—ovarian cancer	1.67e-05	0.000455	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—ovarian cancer	1.67e-05	0.000454	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Docetaxel—ovarian cancer	1.66e-05	0.000452	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—ovarian cancer	1.66e-05	0.000452	CcSEcCtD
Ixabepilone—Fatigue—Docetaxel—ovarian cancer	1.66e-05	0.000451	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—ovarian cancer	1.66e-05	0.000451	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—ovarian cancer	1.66e-05	0.000451	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—ATF3—ovarian cancer	1.66e-05	0.000864	CbGpPWpGaD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	1.65e-05	0.000863	CbGpPWpGaD
Ixabepilone—Immune system disorder—Epirubicin—ovarian cancer	1.65e-05	0.000449	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—ovarian cancer	1.65e-05	0.000448	CcSEcCtD
Ixabepilone—Constipation—Docetaxel—ovarian cancer	1.65e-05	0.000448	CcSEcCtD
Ixabepilone—Pain—Docetaxel—ovarian cancer	1.65e-05	0.000448	CcSEcCtD
Ixabepilone—Chills—Epirubicin—ovarian cancer	1.64e-05	0.000446	CcSEcCtD
Ixabepilone—Asthenia—Paclitaxel—ovarian cancer	1.63e-05	0.000443	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND2—ovarian cancer	1.62e-05	0.000845	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—ATF3—ovarian cancer	1.62e-05	0.000845	CbGpPWpGaD
Ixabepilone—Alopecia—Epirubicin—ovarian cancer	1.61e-05	0.000439	CcSEcCtD
Ixabepilone—Pruritus—Paclitaxel—ovarian cancer	1.61e-05	0.000437	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—ovarian cancer	1.6e-05	0.000435	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—SKP2—ovarian cancer	1.6e-05	0.000836	CbGpPWpGaD
Ixabepilone—Erythema multiforme—Doxorubicin—ovarian cancer	1.6e-05	0.000435	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—ovarian cancer	1.59e-05	0.000433	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—MLH1—ovarian cancer	1.58e-05	0.000826	CbGpPWpGaD
Ixabepilone—Eye disorder—Doxorubicin—ovarian cancer	1.58e-05	0.00043	CcSEcCtD
Ixabepilone—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	1.58e-05	0.000823	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—TUBB3—ovarian cancer	1.57e-05	0.000822	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Docetaxel—ovarian cancer	1.57e-05	0.000428	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—ovarian cancer	1.57e-05	0.000427	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—SKP2—ovarian cancer	1.57e-05	0.000817	CbGpPWpGaD
Ixabepilone—Diarrhoea—Paclitaxel—ovarian cancer	1.55e-05	0.000423	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CHEK2—ovarian cancer	1.55e-05	0.000807	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.54e-05	0.000804	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.54e-05	0.000804	CbGpPWpGaD
Ixabepilone—Angiopathy—Doxorubicin—ovarian cancer	1.53e-05	0.000417	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—ovarian cancer	1.53e-05	0.000416	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—ovarian cancer	1.53e-05	0.000415	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	1.53e-05	0.000797	CbGpPWpGaD
Ixabepilone—Mediastinal disorder—Doxorubicin—ovarian cancer	1.52e-05	0.000414	CcSEcCtD
Ixabepilone—Abdominal pain—Docetaxel—ovarian cancer	1.52e-05	0.000414	CcSEcCtD
Ixabepilone—Body temperature increased—Docetaxel—ovarian cancer	1.52e-05	0.000414	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—ovarian cancer	1.52e-05	0.000413	CcSEcCtD
Ixabepilone—Dizziness—Paclitaxel—ovarian cancer	1.5e-05	0.000408	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—ovarian cancer	1.49e-05	0.000406	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.49e-05	0.000776	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.49e-05	0.000776	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.49e-05	0.000776	CbGpPWpGaD
Ixabepilone—Mental disorder—Doxorubicin—ovarian cancer	1.48e-05	0.000403	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—ovarian cancer	1.47e-05	0.0004	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—ovarian cancer	1.47e-05	0.0004	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—ATF3—ovarian cancer	1.45e-05	0.000759	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND2—ovarian cancer	1.45e-05	0.000756	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MLH1—ovarian cancer	1.45e-05	0.000756	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—BRCA1—ovarian cancer	1.45e-05	0.000756	CbGpPWpGaD
Ixabepilone—Vomiting—Paclitaxel—ovarian cancer	1.44e-05	0.000393	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.44e-05	0.000752	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.44e-05	0.00075	CbGpPWpGaD
Ixabepilone—Rash—Paclitaxel—ovarian cancer	1.43e-05	0.000389	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—SKP2—ovarian cancer	1.43e-05	0.000747	CbGpPWpGaD
Ixabepilone—Dermatitis—Paclitaxel—ovarian cancer	1.43e-05	0.000389	CcSEcCtD
Ixabepilone—Syncope—Epirubicin—ovarian cancer	1.43e-05	0.000388	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—ovarian cancer	1.42e-05	0.000387	CcSEcCtD
Ixabepilone—Headache—Paclitaxel—ovarian cancer	1.42e-05	0.000387	CcSEcCtD
Ixabepilone—Hypersensitivity—Docetaxel—ovarian cancer	1.42e-05	0.000386	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCNE1—ovarian cancer	1.42e-05	0.00074	CbGpPWpGaD
Ixabepilone—Muscle spasms—Doxorubicin—ovarian cancer	1.42e-05	0.000385	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.41e-05	0.000735	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Epirubicin—ovarian cancer	1.4e-05	0.00038	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—TYMS—ovarian cancer	1.39e-05	0.000727	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.39e-05	0.000726	CbGpPWpGaD
Ixabepilone—Cough—Epirubicin—ovarian cancer	1.39e-05	0.000378	CcSEcCtD
Ixabepilone—Asthenia—Docetaxel—ovarian cancer	1.38e-05	0.000376	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—PPP2R1A—ovarian cancer	1.37e-05	0.000713	CbGpPWpGaD
Ixabepilone—Pruritus—Docetaxel—ovarian cancer	1.36e-05	0.00037	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—ovarian cancer	1.36e-05	0.00037	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.36e-05	0.00071	CbGpPWpGaD
Ixabepilone—Chest pain—Epirubicin—ovarian cancer	1.35e-05	0.000368	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—ovarian cancer	1.35e-05	0.000368	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—ovarian cancer	1.35e-05	0.000368	CcSEcCtD
Ixabepilone—Nausea—Paclitaxel—ovarian cancer	1.35e-05	0.000367	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.35e-05	0.000366	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND2—ovarian cancer	1.34e-05	0.0007	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—ATF3—ovarian cancer	1.33e-05	0.000694	CbGpPWpGaD
Ixabepilone—Syncope—Doxorubicin—ovarian cancer	1.32e-05	0.000359	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—ovarian cancer	1.32e-05	0.000358	CcSEcCtD
Ixabepilone—Diarrhoea—Docetaxel—ovarian cancer	1.32e-05	0.000358	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—BRCA2—ovarian cancer	1.31e-05	0.000684	CbGpPWpGaD
Ixabepilone—Oedema—Epirubicin—ovarian cancer	1.3e-05	0.000353	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—ovarian cancer	1.29e-05	0.000352	CcSEcCtD
Ixabepilone—Infection—Epirubicin—ovarian cancer	1.29e-05	0.000351	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—ovarian cancer	1.28e-05	0.000349	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CHEK2—ovarian cancer	1.28e-05	0.000668	CbGpPWpGaD
Ixabepilone—Shock—Epirubicin—ovarian cancer	1.28e-05	0.000347	CcSEcCtD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.27e-05	0.000665	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Epirubicin—ovarian cancer	1.27e-05	0.000346	CcSEcCtD
Ixabepilone—Dizziness—Docetaxel—ovarian cancer	1.27e-05	0.000346	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—ovarian cancer	1.27e-05	0.000346	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CCNE1—ovarian cancer	1.27e-05	0.000662	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	1.27e-05	0.000661	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.26e-05	0.00066	CbGpPWpGaD
Ixabepilone—Skin disorder—Epirubicin—ovarian cancer	1.26e-05	0.000343	CcSEcCtD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.26e-05	0.000657	CbGpPWpGaD
Ixabepilone—Arthralgia—Doxorubicin—ovarian cancer	1.25e-05	0.000341	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—ovarian cancer	1.25e-05	0.000341	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—ovarian cancer	1.25e-05	0.000341	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—BIRC5—ovarian cancer	1.25e-05	0.000654	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TYMS—ovarian cancer	1.25e-05	0.00065	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.24e-05	0.000338	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—ovarian cancer	1.24e-05	0.000337	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND2—ovarian cancer	1.23e-05	0.000641	CbGpPWpGaD
Ixabepilone—Vomiting—Docetaxel—ovarian cancer	1.22e-05	0.000333	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.22e-05	0.000637	CbGpPWpGaD
Ixabepilone—Rash—Docetaxel—ovarian cancer	1.21e-05	0.00033	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—ovarian cancer	1.21e-05	0.00033	CcSEcCtD
Ixabepilone—Dermatitis—Docetaxel—ovarian cancer	1.21e-05	0.00033	CcSEcCtD
Ixabepilone—Headache—Docetaxel—ovarian cancer	1.21e-05	0.000328	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—ovarian cancer	1.2e-05	0.000327	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CCND2—ovarian cancer	1.2e-05	0.000626	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—BRCA1—ovarian cancer	1.2e-05	0.000626	CbGpPWpGaD
Ixabepilone—Infection—Doxorubicin—ovarian cancer	1.19e-05	0.000325	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.18e-05	0.000322	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—ovarian cancer	1.18e-05	0.000321	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—ovarian cancer	1.18e-05	0.00032	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—ovarian cancer	1.18e-05	0.00032	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	1.18e-05	0.000613	CbGpPWpGaD
Ixabepilone—Insomnia—Epirubicin—ovarian cancer	1.17e-05	0.000319	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.17e-05	0.000613	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.17e-05	0.000613	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CHEK2—ovarian cancer	1.17e-05	0.000611	CbGpPWpGaD
Ixabepilone—Skin disorder—Doxorubicin—ovarian cancer	1.17e-05	0.000317	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—ovarian cancer	1.17e-05	0.000317	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—ovarian cancer	1.16e-05	0.000315	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	1.16e-05	0.000604	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.16e-05	0.000604	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TYMS—ovarian cancer	1.15e-05	0.000603	CbGpPWpGaD
Ixabepilone—Anorexia—Doxorubicin—ovarian cancer	1.15e-05	0.000311	CcSEcCtD
Ixabepilone—Nausea—Docetaxel—ovarian cancer	1.14e-05	0.000311	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.13e-05	0.000592	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PPP2R1A—ovarian cancer	1.13e-05	0.000591	CbGpPWpGaD
Ixabepilone—Decreased appetite—Epirubicin—ovarian cancer	1.13e-05	0.000307	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—ovarian cancer	1.12e-05	0.000305	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.12e-05	0.000305	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—BIRC5—ovarian cancer	1.12e-05	0.000585	CbGpPWpGaD
Ixabepilone—Fatigue—Epirubicin—ovarian cancer	1.12e-05	0.000304	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.12e-05	0.000583	CbGpPWpGaD
Ixabepilone—Constipation—Epirubicin—ovarian cancer	1.11e-05	0.000302	CcSEcCtD
Ixabepilone—Pain—Epirubicin—ovarian cancer	1.11e-05	0.000302	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.1e-05	0.000573	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND2—ovarian cancer	1.1e-05	0.000573	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—BRCA1—ovarian cancer	1.1e-05	0.000573	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.09e-05	0.000298	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—ovarian cancer	1.09e-05	0.000295	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—BRCA2—ovarian cancer	1.08e-05	0.000566	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TERT—ovarian cancer	1.08e-05	0.000566	CbGpPWpGaD
Ixabepilone—Paraesthesia—Doxorubicin—ovarian cancer	1.08e-05	0.000293	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCNE1—ovarian cancer	1.07e-05	0.000561	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.07e-05	0.00056	CbGpPWpGaD
Ixabepilone—Dyspnoea—Doxorubicin—ovarian cancer	1.07e-05	0.000291	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—ovarian cancer	1.06e-05	0.000289	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TYMS—ovarian cancer	1.06e-05	0.000551	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCNE1—ovarian cancer	1.05e-05	0.000549	CbGpPWpGaD
Ixabepilone—Decreased appetite—Doxorubicin—ovarian cancer	1.04e-05	0.000284	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	1.04e-05	0.000542	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.04e-05	0.000282	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—ovarian cancer	1.04e-05	0.000282	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—PPP2R1A—ovarian cancer	1.04e-05	0.00054	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.03e-05	0.000539	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TYMS—ovarian cancer	1.03e-05	0.000539	CbGpPWpGaD
Ixabepilone—Pain—Doxorubicin—ovarian cancer	1.03e-05	0.000279	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—ovarian cancer	1.03e-05	0.000279	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—ovarian cancer	1.03e-05	0.000279	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—ovarian cancer	1.03e-05	0.000279	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—BRCA2—ovarian cancer	9.92e-06	0.000518	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.82e-06	0.000267	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.64e-06	0.000503	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCNE1—ovarian cancer	9.61e-06	0.000502	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—ovarian cancer	9.57e-06	0.00026	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—ovarian cancer	9.5e-06	0.000258	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—ovarian cancer	9.5e-06	0.000258	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—BIRC5—ovarian cancer	9.49e-06	0.000496	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TYMS—ovarian cancer	9.44e-06	0.000493	CbGpPWpGaD
Ixabepilone—Asthenia—Epirubicin—ovarian cancer	9.32e-06	0.000253	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—BIRC5—ovarian cancer	9.28e-06	0.000484	CbGpPWpGaD
Ixabepilone—Pruritus—Epirubicin—ovarian cancer	9.19e-06	0.00025	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—TERT—ovarian cancer	8.99e-06	0.000469	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—ovarian cancer	8.88e-06	0.000242	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—ovarian cancer	8.85e-06	0.000241	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.82e-06	0.00046	CbGpPWpGaD
Ixabepilone—Asthenia—Doxorubicin—ovarian cancer	8.62e-06	0.000234	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—ovarian cancer	8.59e-06	0.000233	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—ovarian cancer	8.5e-06	0.000231	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—BIRC5—ovarian cancer	8.49e-06	0.000443	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—ovarian cancer	8.26e-06	0.000224	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—TERT—ovarian cancer	8.22e-06	0.000429	CbGpPWpGaD
Ixabepilone—Diarrhoea—Doxorubicin—ovarian cancer	8.22e-06	0.000224	CcSEcCtD
Ixabepilone—Rash—Epirubicin—ovarian cancer	8.19e-06	0.000223	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—ovarian cancer	8.18e-06	0.000222	CcSEcCtD
Ixabepilone—Headache—Epirubicin—ovarian cancer	8.13e-06	0.000221	CcSEcCtD
Ixabepilone—Dizziness—Doxorubicin—ovarian cancer	7.94e-06	0.000216	CcSEcCtD
Ixabepilone—Nausea—Epirubicin—ovarian cancer	7.71e-06	0.00021	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—ovarian cancer	7.64e-06	0.000208	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—ovarian cancer	7.57e-06	0.000206	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—ovarian cancer	7.57e-06	0.000206	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—ovarian cancer	7.53e-06	0.000205	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	7.35e-06	0.000384	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—ovarian cancer	7.14e-06	0.000194	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—ovarian cancer	7.01e-06	0.000366	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MMP2—ovarian cancer	6.81e-06	0.000356	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MMP2—ovarian cancer	6.81e-06	0.000356	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MMP2—ovarian cancer	6.58e-06	0.000344	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1B—ovarian cancer	6.57e-06	0.000343	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—MMP2—ovarian cancer	6.37e-06	0.000333	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—ovarian cancer	6.27e-06	0.000327	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—MMP2—ovarian cancer	6.23e-06	0.000325	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	6.09e-06	0.000318	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.81e-06	0.000303	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MAPK3—ovarian cancer	5.78e-06	0.000302	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CXCL8—ovarian cancer	5.66e-06	0.000296	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CXCL8—ovarian cancer	5.66e-06	0.000296	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—ovarian cancer	5.63e-06	0.000294	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MMP2—ovarian cancer	5.59e-06	0.000292	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	5.57e-06	0.000291	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MAPK1—ovarian cancer	5.5e-06	0.000287	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	5.49e-06	0.000287	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CXCL8—ovarian cancer	5.47e-06	0.000285	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1B—ovarian cancer	5.45e-06	0.000284	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	5.41e-06	0.000283	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.31e-06	0.000277	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CXCL8—ovarian cancer	5.3e-06	0.000276	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTNNB1—ovarian cancer	5.22e-06	0.000273	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTNNB1—ovarian cancer	5.22e-06	0.000273	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—ovarian cancer	5.2e-06	0.000271	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CXCL8—ovarian cancer	5.18e-06	0.00027	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MAPK3—ovarian cancer	5.17e-06	0.00027	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MMP2—ovarian cancer	5.12e-06	0.000267	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTNNB1—ovarian cancer	5.04e-06	0.000263	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—ovarian cancer	5.03e-06	0.000263	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1B—ovarian cancer	4.98e-06	0.00026	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MAPK1—ovarian cancer	4.92e-06	0.000257	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTNNB1—ovarian cancer	4.89e-06	0.000255	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.79e-06	0.00025	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTNNB1—ovarian cancer	4.78e-06	0.000249	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—ovarian cancer	4.75e-06	0.000248	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—ovarian cancer	4.66e-06	0.000243	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CXCL8—ovarian cancer	4.65e-06	0.000243	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.56e-06	0.000238	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.38e-06	0.000229	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTNNB1—ovarian cancer	4.29e-06	0.000224	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MAPK3—ovarian cancer	4.29e-06	0.000224	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—ovarian cancer	4.26e-06	0.000223	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CXCL8—ovarian cancer	4.25e-06	0.000222	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.17e-06	0.000218	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—ovarian cancer	4.17e-06	0.000218	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—ovarian cancer	4.13e-06	0.000216	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MAPK1—ovarian cancer	4.08e-06	0.000213	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTNNB1—ovarian cancer	3.92e-06	0.000205	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MAPK3—ovarian cancer	3.92e-06	0.000205	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—ovarian cancer	3.81e-06	0.000199	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MAPK1—ovarian cancer	3.73e-06	0.000195	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—ovarian cancer	3.42e-06	0.000179	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NME2—ovarian cancer	3.35e-06	0.000175	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—ovarian cancer	3.13e-06	0.000163	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYTB—ovarian cancer	2.16e-06	0.000113	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.88e-06	9.84e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.88e-06	9.84e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—YAP1—ovarian cancer	1.26e-06	6.6e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—FASN—ovarian cancer	1.03e-06	5.38e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.01e-06	5.29e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	9.79e-07	5.11e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	9.39e-07	4.9e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	8.33e-07	4.35e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCB1—ovarian cancer	7.73e-07	4.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMS—ovarian cancer	7.59e-07	3.96e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CAV1—ovarian cancer	6.12e-07	3.19e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.57e-07	2.91e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.9e-07	2.56e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.27e-07	2.23e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—ovarian cancer	3.69e-07	1.93e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.6e-07	1.36e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—ovarian cancer	2.13e-07	1.11e-05	CbGpPWpGaD
